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Medicines that Kill:

“At least 200,000 lives could be saved in Africa every year if there were not [sic]
fake medicines”
Tanzania Daily News, 31 March 2010 1
Counterfeit drugs are a growing threat to public health care systems

around the world, particularly to those in the developing world. African

countries, in recent years, have fallen victim to this trade. Many African public
healthcare systems already struggle to cope with the strain that diseases like

malaria, tuberculosis and HIV/ AIDS place on them. 2 Therefore, the effects of
counterfeit drugs are adversely felt and exceptionally hard to deal with. Nigeria,

once a haven for these drugs, has had great success in combating the issue. Many
attribute Nigeria’s success to the efforts of Dora Akunyili 3, 4, the head of the

National Agency for Food and Drug Administration and Control (NAFDAC).

Nigeria’s success in eradicating counterfeit drugs from their pharmaceutical
market gives many other African countries hope, and something to aspire to.
Countries like Kenya and Tanzania, which have only recently begun to tackle the

counterfeit trade, stand to learn a great deal from Nigeria’s example. If other
countries in Africa do not follow in Nigeria’s footsteps and work towards better

1 "allAfrica.com: Tanzania: Fake Medicines Are Sold in Country." allAfrica.com: Home. Tanzania
Daily News, 31 Mar. 2010. Web. 14 Dec. 2011.
<http://allafrica.com/stories/201004020870.html>.
2 Ambali, A , J Mugabe, and C Mutero. 2009. "Science, Technology and Innovation for Public
Health in Africa ( Overview)." www.nepadst.org. New Partnership for Africa’s Development
(NEPAD), n.d. Web. 11 Dec. 2011. <New Partnership for Africa’s Development (NEPAD)>.
3 Bate, Roger. 2008. Making a killing: the deadly implications of the counterfeit drug trade.
Washington, D.C.: AEI Press; p.20
4 Dora Nkem Akunyili "the iron lady" b. July 14, 1954,is a Nigerian internationally renowned
pharmacist and the former Director General of NAFDAC (National Agency for Food and Drug
Administration and Control). She is the current Minister of Information and Communications .
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drug regulation and legislation, then many African nations are greatly in danger

of undoing the efforts of African healthcare workers who have laboured
tirelessly to improve the healthcare systems for decades.

With this in mind, it becomes increasingly evident why the issue of

counterfeit drugs in Africa needs to be addressed. This paper will attempt to
evaluate the extent of the counterfeit drug trade in Africa and what aspects of it
are particularly unique. Based on this, an analysis of why Africa is particularly

susceptible; particular attention will be paid to the prevalence of the problem in

Nigeria, Kenya and Tanzania, and their efforts to combat the issue. Will
counterfeit drugs succeed in further suppressing the African healthcare system,
or will Africans rise to the challenge and overcome this illegal and deathly trade?

Nigeria is an example of a country that has been very successful at

combating the issue, whereas Kenya and Tanzania are countries that are at the
elementary stages of dealing with it. The experiences of these countries, Dora

Akunyili and the World Health Organizations guidelines for combating this issue
will then hopefully allow for a conclusion to be reached on the methods that have

worked best in dealing with drug counterfeiting in Africa. In addition, the role of
technology, and particularly the role of text messaging in drug certification as a
possible solution to the problem, will be evaluated. Finally, an evaluation of the
possible future outcomes of the situation in Africa will then be made based on
expert opinion and facts on the ground.
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The Importance of Defining the Counterfeit Drug:

There is no universally accepted term for what constitutes a counterfeit

drug; definitions vary from country to country. In most cases, the definition that

the World Health Organization (WHO) offers is the most widely accepted one.
The WHO defines a counterfeit drug as:

А counterfeit medicine is one, which is deliberately and fraudulently
mislabeled with respect to identity and/or source. Counterfeiting can
apply to both branded and generic products and counterfeit products may
include products with the correct ingredients or with the wrong
ingredients, without active ingredients, with insufficient active
ingredients or with fake packaging. 5

The definition offered by the WHO allows for some form of uniformity

among nations. Nonetheless, the fact that there is no internationally agreed upon

definition makes it difficult to adequately tackle the issue. How can a substance
be eradicated when there is no agreement as to what that substance is? Most
countries take the definition offered by the WHO and adapt it for local use.
Unfortunately, some countries, like Kenya, do this by redefining the definition of
counterfeit drugs to include generics. 6 Organizations, like Regional Network for

Equity in Health in East and Southern Africa (EQUINET), feel that this is a

dangerous adaption to make, because for many Africans generic drugs make
treatment not only affordable, but also possible. By including generic drugs in

their definition of counterfeit drugs, countries like Kenya risk alienating many
Africans from medical treatment.
5

World Health Organization. "Counterfeit Medicines." World Health Organization.
www.who.int/medicines/services/counterfeit/impact/ImpactF_S/en/index1.html (accessed
December 12, 2011).
6 CEHRUD (2010) Anti-counterfeiting laws and access to essential medicines in East and
Southern Africa EQUINET, CEHRUD, TARSC Policy brief 22, EQUINET, Harare
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Furthermore, while it may be true that some of the counterfeit drugs in

circulation in the continent are of generic branding, that does not mean that all

generic drugs are counterfeited. Generic drugs are not, by definition,

counterfeited drugs. They are simply the unbranded versions of medications that
have had their patents expire. 7 Concerned about the inclusion of generic drugs

by some African nations, who have started their own initiatives to combat drug

counterfeiting, in their definition a group, has spurred a group of African

legislators band together in response. Using working policies drafted by regional
and governmental bodies throughout East Africa these legislators aim to use

these polices as a basis of establishing a robust legal framework that tackles the
issue without including generic drugs. 8 They hope that a shared definition, which

excludes generic drugs, but imposes strict penalties on drug counterfeiters, will
allow African policy makers and healthcare workers to “understand the true

extent of the problem at global level” 9, thereby, allowing them to better combat
the issue within the continent.

When Did Drug Counterfeiting Start and What are the Facts on the Ground like
Today?

Data on when counterfeited drugs first appeared on the continent is

scarce. However, if we use Nigeria as an indicator, we can trace the appearance
World Health Organization. "Multisource (generic) Pharmaceutical Products: Guidelines on
Registration Requirements to Establish Interchangeability.” (World Health Organization
International.
www.who.int/medicines/services/expertcommittees/pharmprep/QAS04_093Rev4_final.pdf
(accessed December 12, 2011).
8 CEHRUD (2010) Anti-counterfeiting laws and access to essential medicines in East and
Southern Africa EQUINET, CEHRUD, TARSC Policy brief 22, EQUINET, Harare
9 World Health Organization. "Counterfeit Medicines." World Health Organization.
www.who.int/medicines/services/counterfeit/impact/ImpactF_S/en/index1.html (accessed
December 12, 2011).
7
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of counterfeit drugs on the continent back to 1968, which is when counterfeit

drugs first started to appear in Nigeria, according to Dora Akunyili. 10 The first
incident of mass casualties resulting from large-scale use of counterfeit drugs

occurred in Niger in 1995, when Nigeria unknowingly donated compromised

meningitis vaccines to Niger 11. The 88,000 donated meningitis vaccines had been

counterfeited. 12 The inoculation of more than 50,000 people with the vaccine
resulted in the deaths of 2,500 people. Unfortunately, apart from this particular

incident, there are no mishaps or indicators to suggest the prevalence of
counterfeit drugs in Nigeria and its neighboring countries at the time.

Information on the occurrence of counterfeit drugs within the region and

the wider continent between 1968 to the early the 2000s is almost nonexistent.

By 2002 statistics on the prevalence of counterfeit drugs in Nigeria became

available, although there were many discrepancies on what the exact statistics
were. Most of the values obtained were guestimates as Nigerian officials did not
have the means, such as adequate manpower and management, to provide

accurate values. Nigerian officials predicted that counterfeit drugs accounted for

40% of the pharmaceutical market, whereas some studies suggest that as much
as 85% of the drugs in circulation in Nigeria were counterfeit. 13

10 Raufu , Abiodun. 2006. "Nigeria Leads Fight Against “Killer” Counterfeit Drugs." World Health
Organization. www.who.int/medicines/services/counterfeit/impact/ImpactF_S/en/index1.html
(accessed December 11, 2011).
11 Raufu , Abiodun. 2006. "Nigeria Leads Fight Against “Killer” Counterfeit Drugs ." World Health
Organization . www.who.int/medicines/services/counterfeit/impact/ImpactF_S/en/index1.html
(accessed December 11, 2011).
12 Ibid
13 Bate, Roger. 2008. Making a killing: the deadly implications of the counterfeit drug trade.
Washington, D.C.: AEI Press; 46
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Subsequently, in response to these staggering numbers, Nigeria took

great strides to combat the issue. As of 2006, counterfeit drugs only make up

16% of the drugs in circulation in Nigeria 14. Meanwhile, in the rest of Africa the

situation has been worsening, and counterfeit drugs have become an increasing

threat. Recent studies show that counterfeit drugs are in greater circulation in

the region than in Nigeria. In a study conducted in 2010, across 17 different Sub-

Saharan African countries, it was found that a median of 20% of the people

interviewed said that they or someone in their household had fallen victim to
counterfeit drugs. 15 The results that the survey yielded showed vast

polarizations in the percentage of occurrence. In Sierra Leone, for instance, 43%
of the drugs in the market are counterfeited. On the other hand, in South Africa

3% of the drugs in circulation are counterfeited.

What Makes Many African Countries Susceptible to Counterfeiting?

South Africa’s low prevalence rate is not indicative of the situation in the

continent. Few countries in the continent are lucky enough to have such low
numbers. The reasons for large disparities between countries like South Africa

and Sierra Leone are a product of differences in the strength of their healthcare
systems and regulatory bodies. It is regulation that determines how susceptible a

country is to penetration of counterfeit drugs into its pharmaceutical market. A
country like South Africa, which has a one of the best health care systems on the
14

Bate, Roger. 2008. Making a killing: the deadly implications of the counterfeit drug trade.
Washington, D.C.: AEI Press;47
15 Ogisi, Mitchell. "EBSCOhost: Fake Medicine Common in Many Sub-Saharan African Countries ."
EBSCO Publishing Service Selection Page.
http://web.ebscohost.com/ehost/detail?sid=b1785ae3-05e7-4e98-a0e62b8ecf7b5a9d%40sessionmgr11&vid=1&hid=19&bdata=JnNpdGU9ZWhvc3QtbGl2ZQ%3d%3d#
db=buh&AN=66669810 (accessed December 12, 2011).
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African continent, is not very likely to have counterfeit drugs in high
circulation. 16 Meanwhile, other African countries, with less capable regulatory

bodies, are far more susceptible to the uninterrupted distribution of the
counterfeit drugs in their pharmaceutical market. Poor regulatory bodies,

coupled with the prevalence of diseases like malaria, tuberculosis and AIDS, and

an inability to afford expensive medications, means that for the many Africans

who do suffer from these diseases, they may not always be able to afford the

necessary treatment. Few Africans have the luxury of buying the most trusted

brands –which are much harder to counterfeit – but instead they buy the
cheapest option that is available to them.

The cheapest option is more likely to be counterfeited, because in many

counterfeit drugs the active ingredients are replaced by smaller quantities than
the required amount, or in some cases they are replaced with chalk. As a result,

drug counterfeiters can afford to sell these drugs at much lower costs. They sell

them at prices that appeal to the unsuspecting African patient, whilst still being
able to make a profit. These drugs are often sold in non-regulated outlets or in
some cases open markets. When Dora Akunyili first assumed her role as the

head of Nigeria’s NAFDAC, more than half of the drugs in open markets in
Nigeria, like Kano market, were counterfeited 17. When she shut down the Kano18

16 "Healthcare in South Africa." International Expatriate (Expat) Health Insurance, Global Medical
Healthcare - Allianz Worldwide Care. http://www.allianzworldwidecare.com/healthcare-insouth-africa (accessed December 14, 2011).
17 Bad Medicine. DVD. Directed by Karen O'Connor. London: British Broadcasting Corporation,
2005.
18 This is significant because Kano has historically been one of the largest markets in Africa.
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market, and her agents began to confiscate the drugs, and found that the drugs in
Kano market were worth £140,000(about $ 218,858 as of 12th March 2012) 19.

It is not just patients who venture into these markets in search for cheap

drugs. In July 2003, the International Children’s Heart Foundation set up base at

the Enugu Teaching Hospital in Nigeria, to perform heart surgeries on ten
children. During one of the surgeries complications arose, and the child was

injected with adrenaline to remedy the situation. The child did not respond, her
heart failed and she died. Four other children died that day. The adrenaline that
was used had been counterfeited. The hospital had purchased the drug and

various other hospital supplies from an open market in the area. 20 What this

incident illustrates is that even at the hospital level, drug regulation in some

African countries is lax. NAFDAC eventually reprimanded the hospital and
confiscated the fake adrenaline and other counterfeited products. Yet, in spite of
this, the hospital still maintains, “there is no proof to link the deaths of the

patients with the drugs used.” 21 If healthcare institutions do not take

responsibility and do not tighten their drug regulations then African healthcare
institutions will continue to be susceptible to the threat of counterfeited drugs.

Nigeria’s case proves that better regulation will indeed reduce the circulation of

counterfeit drugs; the prevalence of counterfeit drugs in Nigeria only began to
decrease after Dora Akunyili put numerous reforms in place. 22

Frenkiel , Olenka . "One Woman's War with Fake Drugs." BBC NEWS.
http://news.bbc.co.uk/2/hi/programmes/this_world/4656627.stm (accessed December 10,
2011)
20 Ibid
21 Ibid
22 Raufu, Abiodun. "Bulletin of the World Health Organization." World Health Organization.
http://www.who.int/bulletin/volumes/84/9/06-020906/en/ (accessed December 12, 2011).
19
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Some might argue that African illiteracy makes Africans susceptible to the

threat of counterfeited drugs. It is certainly a logical conclusion to reach;

however, it is an incorrect one. Literacy might aid the ordinary African to infer

whether or not a product has bypassed its expiration date. Nevertheless, most

counterfeiters are very good at what they do, and know better than to make their
products so easily detected. In cases where expired drugs are used,

counterfeiters often re-label or repackage the drugs to mask their expiration

date. Regulatory officials seem to agree that it is almost impossible to tell

whether a drug has been counterfeited without a lab test. 23 It is for this reason
that literacy can do little to protect patients from falling victim to the use of
counterfeit drugs.

To further the argument, the correlation between literacy and exposure to

counterfeit drugs is Nigeria, Tanzania and Kenya would suggest that literacy
plays no significant role in protecting individuals; the literacy rates in Nigeria,
Tanzania and Kenya are 60%, 73% and 87% respectively.

24

In Tanzania, where

drug regulation and literacy rates are both mediocre the number of people who
had been affected or had a member of their household affected by counterfeit

drugs stands at 24%. However, in Kenya where regulation is poor and literacy is
high, the percentage of counterfeit drugs in the market is 25%. Meanwhile, in
Gibson , Hannah . "A dangerous case of mistaken identity: Counterfeit medicines in West
Africa." Consultancy Africa Intelligence - Assist | Inform | Empower.
http://www.consultancyafrica.com/index.php?option=com_content&view=article&id=460:adangerous-case-of-mistaken-identity-counterfeit-medicines-in-west-africa&catid=60:conflictterrorism-discussion-papers&Itemid=265 (accessed December 14, 2011).
24 "UNICEF - Information by country." UNICEF - UNICEF Home.
http://www.unicef.org/infobycountry/ (accessed December 12, 2011).
23
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Nigeria, where regulation is comparatively much stricter, but literacy is
comparatively lower, the percentage of people that have been exposed to

counterfeited drugs is 20%. 25 These numbers illustrate that literacy does little

to help individuals living in these countries to distinguish between the genuine
and counterfeited versions of the drugs. Therefore, there it may be said that

there is no correlation between literacy and high prevalence rates of drug
counterfeiting.

Higher literacy rates will not eradicate counterfeit drugs in

Africa, but better drug regulation will. Tanzania and Kenya may have surpassed

Nigeria in an effort to improve literacy rates, but Nigeria has surpassed them in

its effort to eradicate counterfeit drugs. Both countries could learn a great deal
from Nigeria, and Akunyili’s efforts to eradicate drug counterfeiting.
What Can Other African Policy Makers Learn From Dora Akunyili?

Dora Akunyili, a former professor of pharmacology 26, became the Director

General of NAFDAC in 2001 and has held that post ever since. 27 Her first order of
business was to fire her most corrupt officers. She changed the staff who were

already working there and hired “a new team of female inspectors and
pharmacists (she believes most men are too easily tempted by bribes) and

Ogisi, Mitchell. " Fake Medicine Common in Many Sub-Saharan African Countries." Gallup.Com
- Daily News, Polls, Public Opinion on Government, Politics, Economics, Management.
http://www.gallup.com/poll/149942/fake-medicine-common-sub-saharan-africancountries.aspx (accessed December 13, 2011).
26 Raufu , Abiodun. 2006. "Nigeria Leads Fight Against “Killer” Counterfeit Drugs ." World Health
Organization . www.who.int/medicines/services/counterfeit/impact/ImpactF_S/en/index1.html
(accessed December 11, 2011).
27 Larkin, Marilynn. "ScienceDirect - The Lancet Infectious Diseases : Dora Akunyili: battling
against counterfeit drugs." ScienceDirect - Home .
http://www.sciencedirect.com/science/article/pii/S1473309906705758 (accessed December
14, 2011).
25
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started to prosecute importers of fake drugs”. 28 To boost morale amongst the

workers she gave them incentives like trips abroad, better facilities and better
working conditions. 29 The corruption that had taken place, preceding Akunyili’s

arrival undoubtedly accounted, to certain extent, for why there were so many

counterfeit drugs in circulation. Through the elimination of “systems in which
informal payments can be easily made in order to pass counterfeits through

bureaucratic barriers”, 30 Akunyili could focus more of her efforts on

investigating possible counterfeiters instead of her own personnel, thus vastly
improving the efficiency of NAFDAC.

Next, Akunyili created a campaign against drug counterfeiting. A series of

public service announcements and infomercials were released to inform

Nigerians of the threat that counterfeit drugs posed to their health. These

infomercials not only alerted Nigerians to the issue, but they armored Nigerians
with the knowledge they needed to be able to undertake the necessary

precautions and alerted them to the signs they should look out for when

purchasing medications. 31 Television commercials were not the only form of
media used, as not all Nigerians have access to television. Radio services and
newspapers were utilized as well. Newspapers were to publish a regularly
28 Frenkiel , Olenka . "One Woman's War with Fake Drugs." BBC NEWS.
http://news.bbc.co.uk/2/hi/programmes/this_world/4656627.stm (accessed December 10,
2011)
29 Raufu , Abiodun. 2006. "Nigeria Leads Fight Against “Killer” Counterfeit Drugs ." World Health
Organization . www.who.int/medicines/services/counterfeit/impact/ImpactF_S/en/index1.html
(accessed December 11, 2011).
30 Fenoff, Roy S., and Jeremy M. Wilson. "Africa's Counterfeit Pharmaceutical Epidemic: The Road
Ahead." Anti Counterfeiting And Product Protection Programme. University of Michigan, 1 Oct.
2009. Web. 7 Nov. 2011. <http://acappp.msu.edu/sites/default/files/publications/Africa%20Pharma%20Paper.pdf>.
31 Bad Medicine. DVD. Directed by Karen O'Connor. London: British Broadcasting Corporation,
2005.
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updated list of the drugs that had been counterfeited recently. As a result of

efforts to raise public awareness of the issue, today 83% of the population is
aware of the presence of counterfeit drugs in their country, compared to the
66% of Tanzanians and 63% of Kenyans that are aware of the problem. 32

Once Akunyili had settled the Nigerian aspect of the trade, she looked

abroad and followed the counterfeit trail to India and China, which was a very
important step as it had implications for the rest of Africa. African governments
looking to clamp down on counterfeit drug entry into their country could use her
findings in their own countries. She made it her business to engage with drug

regulators in India in an effort to get them to stop exporting “bad medicines” into
Nigeria. Akunyili observed that drug regulations on drugs meant for internal use

in India were much stricter than for drugs that were to be exported to countries
like Nigeria. Angered by the lax regulation standards for exported drugs,

Akunyili made calls for laws to be put in place to ensure that the stricter

regulation be enforced for drugs exported out of India. Drug regulators in India
agreed with Akunyili, and promised to make the necessary changes to the
legislation. After sometime, she saw that no such changes were being made to

the legislation, and so Akuniyli took matters into her own hands. In the NAFDAC

labs, tests were carried out on drugs imported from India and China. Companies,
whose products were found to have been counterfeited consistently, were black

listed. Akunyili was able to black list and eventually ban 19 drugs manufactured

Ogisi, Mitchell. " Fake Medicine Common in Many Sub-Saharan African Countries ." Gallup.Com
- Daily News, Polls, Public Opinion on Government, Politics, Economics, Management .
http://www.gallup.com/poll/149942/fake-medicine-common-sub-saharan-africancountries.aspx (accessed December 13, 2011).
32
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in India. More importantly, Akunyili tightened Nigerian customs on drug imports

coming from abroad. 33

Her crusade to eradicate counterfeit drugs in Nigeria did not go

unnoticed. Drug counterfeiters were so angered by her actions that on March 7th,
2004 they set fire to NAFDAC laboratories and offices 34. Later, they made an

attempt on her life, which she survived without injury. She has also angered

pharmaceutical companies by calling for them to take action and to work
together with governments to help eradicate the problem. Companies, like Pfizer,

whose drugs have been imitated by counterfeiters, are hesitant to respond,

because they do not want their name associated with the counterfeiting. It
reflects badly on them, and could affect their business. Their shareholders might

switch to companies with better reputations and they might have to do massive

recalls in cases where counterfeited versions of their products have resulted in
mass casualties. 35

Akunyili has a vision and she is adamant that she will see it through. She

asserts, “We are not there yet. Even 1% fake drugs is not good enough, because

every life is important”. 36 It is this vision and fearlessness that Tanzanian and
Kenyan policy makers could learn a great deal from. Tanzania, like Nigeria, has a

Food and Drug regulatory body. The Tanzania Food and Drug Authority (TFDA)

Bad Medicine. DVD. Directed by Karen O'Connor. London: British Broadcasting Corporation,
2005.
34 Akunyili, Dora. "Akunyili." Farmacevter utan Gränser Sverige. www.fug.se/ovrigt/Akunyili.pdf
(accessed December 14, 2011).
35 Ibid
36 Raufu , Abiodun. 2006. "Nigeria Leads Fight Against “Killer” Counterfeit Drugs ." World Health
Organization . www.who.int/medicines/services/counterfeit/impact/ImpactF_S/en/index1.html
(accessed December 11, 2011).
33
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was established in 2003 37, thus making it a decade younger than NAFDAC, which
was established in 1993. 38 It has had less time than its Nigerian counterpart, but

it is definitely making great progress. Through the course of the year 2009 the
World Health Organization in conjunction with TFDA worked towards the

improvement of drug regulation and on training 20 TFDA drug inspectors on
detection, identification and investigation of counterfeit medicines. 39 Still, as the
journalist Songa Wa Songa stated, “authorities would need to do extra homework
to win the war” 40. There is a great deal of room for improvement; in order to

combat the issue, Tanzanian authorities need to first establish what the exact
extent of the problem is. Currently, Tanzanian authorities are only able to make

speculations about the market worth of counterfeit drugs in the market, but they
suspect that “racketeers could be walking away with billions of shillings at the

expense the public's wellbeing”. As recently as October 1st, 2011, the TFDA has
conducted sting operations. Nevertheless, as Mr. Songa points out,

“such

sporadic raids have not deterred dealers”. 41 Tanzania must tighten its customs
and borders, especially when its neighbors are struggling to get a hold of the
counterfeit trade in their own countries.

Kenya, a neighbor of Tanzania, is only now beginning to take a more

active role in combatting the issue of counterfeit drugs within its borders. The
http://www.afro.who.int/en/downloads/doc_details/2783-united-republic-of-tanzaniacountry-pharmaceutical-profile-and-npo.html?tmpl=component
38 NAFDAC. "NAFDAC Organisation." NAFDAC.
http://www.nafdac.gov.ng/index.php?option=com_content&view=article&id=46:nafdacorganisation (accessed December 13, 2011).
39 http://www.afro.who.int/en/downloads/doc_details/2783-united-republic-of-tanzaniacountry-pharmaceutical-profile-and-npo.html?tmpl=component
40 Ibid
41 Wa Songa, Songa. "allAfrica.com: Tanzania: Fake Drugs Nightmare." allAfrica.com: Home.
http://allafrica.com/stories/201110090045.html (accessed December 13, 2011).
37
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regulatory board in Kenya, the Pharmacy and Poisons Board, was established
early in 1957, and become recognized as a corporate body in 1993. 42 It is as old

as NAFDAC; yet, it seems to have done much less in comparison. Granted, the

prevalence of counterfeit drugs did not reach as high a percentage as that of
Nigeria, but today, Nigeria has surpassed Kenya in its attempt to eradicate
counterfeit drugs within its borders. In present day Nigeria, somewhere between

16%-20% of the drugs in its market are counterfeited, whereas in Kenya as

much as an estimated 30% of the drugs in circulation are counterfeited 43. The

Kenyan government and the Kenyan Pharmacy and Poisons Board are still
grappling with the issue. In September 2011 it was discovered that at least

16,340 batches of the counterfeit Anti-Retroviral drugs were released into the

pharmaceutical market. According to a reporter:

The ARVs were found to be falsified versions of a World Health
Organization (WHO)-certified generic drug purchased through a
distributor endorsed by the Kenya Pharmacy and Poisons Board (KPPB),
the country's drug regulatory authority. 44
Occurrences such as these indicate that the Kenyan regulatory body

should enforce stricter customs on drug imports. In addition, they should carry

out more frequent inspections, and not rely so much on external organizations,
like the World Health Organization to ensure the safety of the drugs they import.
The World Health Organization has set up a body to monitor and prevent drug

counterfeiting around the world. The International Medical Products Anti-

42 "Pharmacy & Poisons Board | About Pharmacy and Poisons Board." Pharmacy & Poisons Board
| Home. http://www.pharmacyboardkenya.org/index.php?id=109 (accessed December 14,
2011).
43 Ibid

44

All Africa 19 October 2011

AHMED ABUSHOUK 16

Counterfeiting Taskforce (IMPACT) was launched in 2006 45. With an estimated
10% of the worlds drugs supplies suspected to be counterfeit IMPACT will not

always be able to assist very much at the local level. Therefore, it is up to Kenyan
and Tanzanian drug regulators alike to take charge of what happens within their
borders.

The Implications of Counterfeiting:
Economic:

Drug counterfeiting has negative implications for both pharmaceutical

companies and local economies. Counterfeiters cheat large corporations out of

billions of dollars when their fake drugs are purchased instead of genuine drugs.

The counterfeit drugs cause the real drugs to undersell 46. Alternatively, for the
local economy, because counterfeit drugs are smuggled into the country illegally

the counterfeiters avoid paying important duties and sales taxes. Therefore, the
local economy suffers, whilst the patients gain no real benefits. Meanwhile, the
only actors making a profit out of this trade is the counterfeiters themselves.
According to Consultancy Africa:

A 2009 UN report showed that revenues from 45 million fake antimalarial drugs were worth around US$ 438 million, which is greater than
the gross-domestic product (GDP) of Guinea-Bissau. 47

International Medical Products Anti-Counterfeiting Taskforce (IMPACT). "About Us." World
Health Organization. www.who.int/impact/about/en/ (accessed December 14, 2011).
46 Fenoff, Roy S., and Jeremy M. Wilson. "Africa's Counterfeit Pharmaceutical Epidemic: The Road
Ahead." Anti Counterfeiting And Product Protection Programme. University of Michigan, 1 Oct.
2009. Web. 7 Nov. 2011. <http://acappp.msu.edu/sites/default/files/publications/Africa%20Pharma%20Paper.pdf>.
47 Meissner , Richard. "The trade in counterfeit goods: What is it, why is it a problem and what is
its impact on Africa?." Consultancy Africa Intelligence - Assist | Inform | Empower.
http://www.consultancyafrica.com/index.php?option=com_content&view=article&id=475:thetrade-in-counterfeit-goods-what-is-it-why-is-it-a-problem-and-what-is-its45

AHMED ABUSHOUK 17

The lucrative nature of the trade makes it harder to deter, especially if the

selling of one type of drug, anti malarial drugs, is enough to generate wealth
worth the GDP of a small African nation. Moreover, because few African

countries have tough enough penalties on counterfeiting, the economic gains far
outweigh the risks involved. In Nigeria, Akunyili attempted to change the law to

make it harder on the perpetrators, thus deterring them from engaging in

counterfeiting. However, so far the legislation in Nigeria only imposes fines as a
penalty, as opposed to a harsher punishment like jail time.
Social:
Patients who take counterfeits and fail to get better understandably lose
faith in the healing powers of modern medicine, and especially in poor
countries they may turn instead to traditional healers. 48

Apart from putting a strain on the public healthcare system, drug counterfeiting
also instills a great deal of mistrust in patients: Patients may boycott the bio-

medicinal system, because they feel that it has failed them. Officials, like Edith
Ngirwamungu, the president of the Medical Association of Tanzania, fear that by
“having these counterfeit drugs, [it] makes people fearful of conventional drugs

and revert back to traditional drugs”. 49 This in itself may be dangerous, because

at times traditional healers prescribe “western” medication. If these medicines
happen to be counterfeit as well, then the patient will continue to suffer ill health

or worse, be poisoned by the counterfeit drugs. Regardless of which system of
Heller, Matthew. "Report Urges Global Crackdown on Counterfeit Medicines | FairWarning."
FairWarning: News of safety, health and corporate conduct | FairWarning.
http://www.fairwarning.org/2011/02/report-urges-global-crackdown-on-counterfeitmedicines/ (accessed December 14, 2011).
49 IRIN. " IRIN Africa | TANZANIA: Counterfeit drugs put lives at risk | Tanzania | Economy |
Health & Nutrition ." IRIN • humanitarian news and analysis from Africa, Asia and the Middle
East - updated daily . http://www.irinnews.org/report.aspx?reportid=82374 (accessed
December 14, 2011).
48
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healing (biomedical or traditional) they choose to consult, in the end if

counterfeit drugs are involved the patient is the one who suffers – they may

suffer prolonged illness or death. 50
Biomedical:

Perhaps the most devastating consequence of drug counterfeiting is that

it causes drug resistance for fatal diseases like Malaria, Tuberculosis and

HIV/AIDS. Diseases, like malaria and tuberculosis, which were once curable, are
getting increasingly harder to cure. Counterfeit drugs that have trace amounts of

active ingredients cause drug resistance to occur. In response to this recent

surge of drug resistance, many researchers have come to believe that counterfeit
drugs without any active materials are ultimately much safer, than counterfeit

drugs with some active materials. They claim, “low levels of active ingredient
assist the microorganisms in adapting to the drugs making the drugs less
effective”. 51

Drug resistance has had fatal results on children, who have much weaker

immune systems than adults. In the case of malaria, “counterfeit medicines have

been indicated as a major reason why malaria has become, over the past 30
years, the biggest cause of child deaths in Africa, when previously it was an

illness that was easily treated with medicine.” 52 Similarly, there have been
Sengiyumva, Gasirigwa . "allAfrica.com: Tanzania: War On Counterfeit Drugs Still On."
allAfrica.com: Home. http://allafrica.com/stories/201007050338.html (accessed December 14,
2011).
51 Fenoff, Roy S., and Jeremy M. Wilson. "Africa's Counterfeit Pharmaceutical Epidemic: The Road
Ahead." Anti Counterfeiting And Product Protection Programme. University of Michigan, 1 Oct.
2009. Web. 7 Nov. 2011. <http://acappp.msu.edu/sites/default/files/publications/Africa%20Pharma%20Paper.pdf>.
52 Gibson , Hannah . "A dangerous case of mistaken identity: Counterfeit medicines in West
Africa." Consultancy Africa Intelligence - Assist | Inform | Empower.
50
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reports of resistance towards medications for tuberculosis and even antiretroviral drugs.

53

Beyond rendering some of these diseases virtually incurable,

drug resistance has shown that it can create new strains of disease. These new
strains might be even harder to cure than the ones presently in circulation.

According to the World Health Organization, drug resistance will put the

healthcare systems of developing countries in worse shape than they already

are. First, cheap drugs will become ineffective in the treatment of these diseases.

Then, new drugs will have to be developed to replace the old ones, which cost a
great deal of money. It will cost more money than many of these nations can

afford, thus placing an economic burden on these countries. 54 While drug
resistance is a direct consequence of counterfeit drugs that have small amounts
of active ingredients, allergic reactions and possibly even death are the side-

effects of taking drugs with too much active ingredient or ingredients that are
poisonous. These versions of counterfeit drugs evidently cause more direct and
tangible harm. 55

Does Technology Offer the Solution For This Problem?

Large corporations have resorted to using technologies such as

http://www.consultancyafrica.com/index.php?option=com_content&view=article&id=460:adangerous-case-of-mistaken-identity-counterfeit-medicines-in-west-africa&catid=60:conflictterrorism-discussion-papers&Itemid=265 (accessed December 14, 2011).

Harris, Julian, Philip Stevens, and Julian Morris. "Keeping It Real." African Liberty. Health Issues,
May 2009. Web. 7 Nov. 2011. <http://africanliberty.org/pdf/Keepingitreal.pdf>.
54 Kelesidis, Theodore , Iosif Kelesidis, Petros I. Rafailidis, and Matthew E. Falagas. "Counterfeit or
substandard antimicrobial drugs: a review of the scientific evidence." JAC Online: Oxford
Journals. jac.oxfordjournals.org/content/60/2/214.full#xref-fn-1-1 (accessed December 14,
2011).
53
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holograms and barcodes to make their products harder to counterfeit. 56 These

are wasted efforts, because the best counterfeiters have managed to mimic the

holograms and create barcodes that look like carbon copies of those from the big

corporations. In the case of the hologram, officials explain that the ones that are
produced by counterfeiters are dull in comparison to the holograms produced by

the pharmaceutical companies. These indicators are complicated and difficult for

the ordinary person to use when trying to differentiate between the genuine

product and the fake. 57 In addition, these technologies are expensive. Realizing
the many faults of the use of holograms and barcodes, the United States
Pharmacopeial Convention decided to find a much cheaper solution.

They suggested the use of mobile phones by offering the explanation that

it was making use of “a technology that millions of people have access to”. 58 The

system they set up makes use of a unique identification code that each box is
inscribed with. Upon purchase, the customer scratches the box to reveal the

number. The customer will then send a text message to the central register,
which will send a message that indicates whether the product is genuine or

counterfeited. The system has been in use in Nigeria for quite some time, and
was adopted by Kenya in October of 2011.

Orange, a telecommunications

network, is the body that is regulating the use of this system in Kenya. 59 There

are presently no statistics or research to indicate how successful this new system

Harris, Julian, Philip Stevens, and Julian Morris. "Keeping It Real." African Liberty. Health Issues,
May 2009. Web. 7 Nov. 2011. <http://africanliberty.org/pdf/Keepingitreal.pdf>.
57 Bad Medicine. DVD. Directed by Karen O'Connor. London: British Broadcasting Corporation,
2005.
58 Harris, Julian, Philip Stevens, and Julian Morris. "Keeping It Real." African Liberty. Health Issues,
56

May 2009. Web. 7 Nov. 2011. <http://africanliberty.org/pdf/Keepingitreal.pdf>.

"Orange Kenya launches programme to fight counterfeit drugs | Medicalkenya." Medical Kenya:
your best health now. http://medicalkenya.co.ke/2011/10/orange-kenya-launches-programmeto-fight-counterfeit-drugs/ (accessed December 15, 2011).
59

AHMED ABUSHOUK 21

has been, but frequent reports, published by journalists and Non-Governmental
Organizations, like the WHO, would suggest that so far the system seems to be
running very well.

What Does the Future Hold for Counterfeit Drugs in Africa?

Presently, there is no agreement on how to define a counterfeit drug, let
alone a scheme in international law to make counterfeiting a crime and
pursue its perpetrators around the globe. 60

Drug counterfeiting is not an issue that is unique to these countries. It is

an issue that affects most of Sub-Saharan Africa. These countries may have made

strides to combat the issue within their own borders, and they may even have

made vast improvements, but there is only so much that one country can do to
tackle a regional problem. The porous borders between many African nations
means that even if one country, for example, Nigeria, manages to resolve the
issue of counterfeit drugs within its own borders, counterfeit drugs will still be
prevalent, albeit to a lesser extent, unless its neighboring countries do the same.

Eradicating counterfeit drugs from the continent will require the effort of

all affected countries. To start, perhaps, the African Union can formulate a

definition of what a counterfeit drug is, within the context of the African

continent. Once all the countries have a clear idea of what they are looking to

eradicate, they can then form a legal collective, such as the Africa and the East

African Society, and create laws that impose more deterrent punishments on the
drug counterfeiters. Many African officials see tougher penalties as the next

Bate, Roger, and Amir Attaran . "A counterfeit drug treaty: great idea, wrong implementation :
The Lancet." TheLancet.com - Home Page.
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2810%2961416-X/fulltext
(accessed December 14, 2011).
60
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logical step towards the eradication of this lethal trade. 61 There are no estimates

on when Africa will be free of counterfeit drugs, however, even without and end
in sight many African countries are taking the necessary steps to safeguard the
welfare of their people.

Mcdiarmid, Jessica , and Poindexter Sama. "allAfrica.com: Sierra Leone: Substandard And
Counterfeit Drugs Flood the Market." allAfrica.com: Home.
http://allafrica.com/stories/201106190011.html (accessed December 14, 2011).
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